aureus pathogenicity through their ability to bind fibronectin and fibrinogen and to initiate integrin-mediated intracellular uptake of the bacteria by non-professional phagocytes such as endothelial cells or osteoblasts [2, 3]. The invasion of host cells by S. aureus eventually leads to the formation of an intracytoplasmic
reservoir, where bacteria remain protected from the action of cell- and antibody-mediated immune response and from that of most antimicrobial agents. This bacterial sanctuarisation makes successful treatment even more challenging and paves the way for infection AMN-107 ic50 relapse [4]. A peculiar difficulty to be faced in treating deep-seated infections is the risk of impaired diffusion of antimicrobial agents at the infection site, where they would AZD1152 only achieve sub-inhibitory concentrations. S. aureus strains challenged with such antibiotic selleck inhibitor concentrations have been shown to exhibit altered phenotypes depending on the molecule tested, including down- or up-regulation of virulence factor expression. For example, beta-lactams enhance the secretion of virulence factors such as
the Panton-Valentine leukocidin and alpha haemolysin, while clindamycin or linezolid exert an inhibitory effect [5–8]. However, most studies on the antibiotic-mediated modulation
of protein expression by S. aureus have focused on secreted exotoxins, and less is known about this modulation with respect to MSCRAMMS, including FnBPA/B. In the present study, we aimed to investigate the impact of sub-inhibitory concentrations of major anti-staphylococcal agents on the adhesion and invasion phenotypes of S. aureus. After in vitro challenge of S. aureus Teicoplanin reference strain 8325-4 and clinical isolates with antibiotics, we explored the following: (i) mRNA expression levels of the fnbA and fnbB genes, which encode FnBPA and B, respectively; (ii) bacterial adhesiveness to immobilised human fibronectin and human osteoblasts in culture; and (iii) bacterial invasion of human osteoblasts. Methods Bacterial strains The bacterial strains used in this study are summarised in Table 1. Laboratory strain 8325-4 and its ΔfnbA/B derivative DU5883 were used as a control for fnbA/B [9]. Clinical isolates were characterised for the presence of the fnbA, fnbB, agr1-4 and mecA genes by PCR as previously described [10, 11], and MLST was performed as described by Enright et al. to identify their genetic background [12].
Related posts:
- aureus (Fig 2A) or S typhimurium (Fig 2B) resulted in markedly
- These methods disrupt the pathogenesis of bacterial infections wi
- RQ: Relative quantity Expression of biofilm-associated genes
- , 2002; Hamamoto et al, 2004) The large size of the silkworm al
- Vibrio cholerae is a Gram-negative aquatic bacterium responsible